Curiox Biosystems Co., a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, have announced a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry.

The agreement combines the Laminar flow-based gentle liquid exchange technology known as C-FREE technology from Curiox with the comprehensive suite of DURAClone dry pre-formulated antibody panels and customized DURA Innovations dry reagent antibody cocktails from Beckman Coulter Life Sciences. This workflow solution overcomes longstanding challenges faced by researchers worldwide, including the need for highly standardised, reproducible, and automated sample preparation for flow cytometry laboratories.

This partnership is expected to accelerate the research and development of next-generation therapies, vaccines, and biomanufacturing processes.

"Our alliance with Beckman Coulter Life Sciences is not just about combining technologies; it's about combining our strengths to empower the scientific community," said Namyong Kim. PhD, CEO of Curiox Biosystems. "By addressing the challenges of standardization, automation, and reproducibility head-on, we are paving the way for significant advancements in research and healthcare."